Liangmei He

4.1k total citations
63 papers, 3.4k citations indexed

About

Liangmei He is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Liangmei He has authored 63 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Immunology, 34 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Liangmei He's work include Immunotherapy and Immune Responses (45 papers), Immune Cell Function and Interaction (15 papers) and RNA Interference and Gene Delivery (14 papers). Liangmei He is often cited by papers focused on Immunotherapy and Immune Responses (45 papers), Immune Cell Function and Interaction (15 papers) and RNA Interference and Gene Delivery (14 papers). Liangmei He collaborates with scholars based in United States, Taiwan and China. Liangmei He's co-authors include Chien‐Fu Hung, T.‐C. Wu, Morris Ling, Wen‐Fang Cheng, Keng‐Fu Hsu, Chee‐Yin Chai, Ya-Chea Tsai, Tae Woo Kim, Jeremy Juang and Zhiping Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Liangmei He

63 papers receiving 3.3k citations

Peers

Liangmei He
Scott A. Hammond United States
Alice J.A.M. Sijts Netherlands
Antonella Vitiello United States
Romina S. Goldszmid United States
Lbachir BenMohamed United States
J P Tite United Kingdom
Liangmei He
Citations per year, relative to Liangmei He Liangmei He (= 1×) peers Timo Sareneva

Countries citing papers authored by Liangmei He

Since Specialization
Citations

This map shows the geographic impact of Liangmei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangmei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangmei He more than expected).

Fields of papers citing papers by Liangmei He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangmei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangmei He. The network helps show where Liangmei He may publish in the future.

Co-authorship network of co-authors of Liangmei He

This figure shows the co-authorship network connecting the top 25 collaborators of Liangmei He. A scholar is included among the top collaborators of Liangmei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangmei He. Liangmei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Chih‐Ping, Yu‐Ping Su, Liangmei He, et al.. (2021). Protein detection in blood with single-molecule imaging. Science Advances. 7(33). 23 indexed citations
2.
He, Liangmei, et al.. (2019). The expression profile of RNA sensors in colorectal cancer and its correlation with cancer stages. Translational Cancer Research. 8(4). 1351–1363. 4 indexed citations
3.
He, Liangmei, et al.. (2019). The expression profile of RNA sensors in colorectal cancer and its correlation with cancer stages. Translational Cancer Research. 8(4). 1351–1363. 9 indexed citations
4.
He, Liangmei, Ya‐Yun Chen, Yuanbing Wu, et al.. (2017). Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis. Cellular and Molecular Life Sciences. 74(13). 2395–2411. 27 indexed citations
5.
Yang, Andrew, Jin Qiu, Benjamin Yang, et al.. (2016). Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant. Cell & Bioscience. 6(1). 17–17. 13 indexed citations
6.
Song, Liwen, Jayne Knoff, Liangmei He, et al.. (2014). Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ. Clinical Cancer Research. 20(21). 5456–5467. 50 indexed citations
7.
Kang, Tae Heung, Jayne Knoff, Benjamin Yang, et al.. (2013). Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide. Cell & Bioscience. 3(1). 48–48. 6 indexed citations
8.
Gomez, Bianca, et al.. (2013). Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen. Cell & Bioscience. 3(1). 29–29. 31 indexed citations
9.
Lü, Dan, Chien‐Fu Hung, Shiwen Peng, et al.. (2007). Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion. Cancer Research. 67(4). 1832–1841. 71 indexed citations
10.
Chang, Chih-Long, Ya-Chea Tsai, Liangmei He, T.‐C. Wu, & Chien‐Fu Hung. (2007). Cancer Immunotherapy Using Irradiated Tumor Cells Secreting Heat Shock Protein 70. Cancer Research. 67(20). 10047–10057. 24 indexed citations
12.
Lin, Cheng‐Tao, Ya-Chea Tsai, Liangmei He, et al.. (2006). A DNA Vaccine Encoding a Codon-Optimized Human Papillomavirus Type 16 E6 Gene Enhances CTL Response and Anti-tumor Activity. Journal of Biomedical Science. 13(4). 481–488. 51 indexed citations
13.
Kim, Tae Woo, Chien‐Fu Hung, Meizi Zheng, et al.. (2004). A DNA Vaccine Co-Expressing Antigen and an Anti-Apoptotic Molecule Further Enhances the Antigen-Specific CD8+ T-Cell Immune Response. Journal of Biomedical Science. 11(4). 493–499. 2 indexed citations
14.
Kim, Tae Woo, Chien‐Fu Hung, Morris Ling, et al.. (2003). Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. Journal of Clinical Investigation. 112(1). 109–117. 132 indexed citations
15.
Kim, Tae Woo, Chien‐Fu Hung, David A. Boyd, et al.. (2003). Enhancing DNA Vaccine Potency by Combining a Strategy to Prolong Dendritic Cell Life with Intracellular Targeting Strategies. The Journal of Immunology. 171(6). 2970–2976. 72 indexed citations
16.
Kim, Tae Woo, Chien‐Fu Hung, Morris Ling, et al.. (2003). Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. Journal of Clinical Investigation. 112(1). 109–117. 136 indexed citations
17.
Trimble, Cornelia L., Cheng‐Tao Lin, Chien‐Fu Hung, et al.. (2003). Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine. 21(25-26). 4036–4042. 153 indexed citations
18.
Cheng, Wen‐Fang, Chien‐Fu Hung, Chee‐Yin Chai, et al.. (2001). Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. Journal of Clinical Investigation. 108(5). 669–678. 215 indexed citations
19.
Hung, Chien‐Fu, Wen‐Fang Cheng, Chee‐Yin Chai, et al.. (2001). Improving Vaccine Potency Through Intercellular Spreading and Enhanced MHC Class I Presentation of Antigen. The Journal of Immunology. 166(9). 5733–5740. 118 indexed citations
20.
Cui, Zhizhong & Liangmei He. (2000). Comparing DNA sequences in glycoprotein I gene (gI) of Marek^s diease viruses of different pathotypes. Virologica Sinica. 15(2). 180–187. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026